IBDEI0B3 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14760,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14760,1,4,0)
 ;;=4^141.9
 ;;^UTILITY(U,$J,358.3,14760,1,5,0)
 ;;=5^Ca Tongue
 ;;^UTILITY(U,$J,358.3,14760,2)
 ;;=CA Tongue^266995
 ;;^UTILITY(U,$J,358.3,14761,0)
 ;;=188.9^^95^849^7
 ;;^UTILITY(U,$J,358.3,14761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14761,1,4,0)
 ;;=4^188.9
 ;;^UTILITY(U,$J,358.3,14761,1,5,0)
 ;;=5^Bladder Ca
 ;;^UTILITY(U,$J,358.3,14761,2)
 ;;=Bladder CA^267253
 ;;^UTILITY(U,$J,358.3,14762,0)
 ;;=191.9^^95^849^10
 ;;^UTILITY(U,$J,358.3,14762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14762,1,4,0)
 ;;=4^191.9
 ;;^UTILITY(U,$J,358.3,14762,1,5,0)
 ;;=5^Brain Ca
 ;;^UTILITY(U,$J,358.3,14762,2)
 ;;=Brain CA^267279
 ;;^UTILITY(U,$J,358.3,14763,0)
 ;;=174.9^^95^849^12
 ;;^UTILITY(U,$J,358.3,14763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14763,1,4,0)
 ;;=4^174.9
 ;;^UTILITY(U,$J,358.3,14763,1,5,0)
 ;;=5^Breast Ca
 ;;^UTILITY(U,$J,358.3,14763,2)
 ;;=Breast CA^267202
 ;;^UTILITY(U,$J,358.3,14764,0)
 ;;=176.9^^95^849^43
 ;;^UTILITY(U,$J,358.3,14764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14764,1,4,0)
 ;;=4^176.9
 ;;^UTILITY(U,$J,358.3,14764,1,5,0)
 ;;=5^Kaposi's Sarcoma
 ;;^UTILITY(U,$J,358.3,14764,2)
 ;;=Kaposi's Sarcoma^107993
 ;;^UTILITY(U,$J,358.3,14765,0)
 ;;=172.9^^95^849^51
 ;;^UTILITY(U,$J,358.3,14765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14765,1,4,0)
 ;;=4^172.9
 ;;^UTILITY(U,$J,358.3,14765,1,5,0)
 ;;=5^Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,14765,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,14766,0)
 ;;=189.0^^95^849^63
 ;;^UTILITY(U,$J,358.3,14766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14766,1,4,0)
 ;;=4^189.0
 ;;^UTILITY(U,$J,358.3,14766,1,5,0)
 ;;=5^Renal Cancer
 ;;^UTILITY(U,$J,358.3,14766,2)
 ;;=Renal Cancer^73523
 ;;^UTILITY(U,$J,358.3,14767,0)
 ;;=189.1^^95^849^64
 ;;^UTILITY(U,$J,358.3,14767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14767,1,4,0)
 ;;=4^189.1
 ;;^UTILITY(U,$J,358.3,14767,1,5,0)
 ;;=5^Renal Pelvis Cancer
 ;;^UTILITY(U,$J,358.3,14767,2)
 ;;=   ^267264
 ;;^UTILITY(U,$J,358.3,14768,0)
 ;;=171.9^^95^849^68
 ;;^UTILITY(U,$J,358.3,14768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14768,1,4,0)
 ;;=4^171.9
 ;;^UTILITY(U,$J,358.3,14768,1,5,0)
 ;;=5^Soft Tissue Sarcoma
 ;;^UTILITY(U,$J,358.3,14768,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,14769,0)
 ;;=186.9^^95^849^70
 ;;^UTILITY(U,$J,358.3,14769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14769,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,14769,1,5,0)
 ;;=5^Testicular Cancer
 ;;^UTILITY(U,$J,358.3,14769,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,14770,0)
 ;;=198.7^^95^849^5
 ;;^UTILITY(U,$J,358.3,14770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14770,1,4,0)
 ;;=4^198.7
 ;;^UTILITY(U,$J,358.3,14770,1,5,0)
 ;;=5^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,14770,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,14771,0)
 ;;=198.5^^95^849^9
 ;;^UTILITY(U,$J,358.3,14771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14771,1,4,0)
 ;;=4^198.5
 ;;^UTILITY(U,$J,358.3,14771,1,5,0)
 ;;=5^Bone Or Bone Marrow Metastasis
 ;;^UTILITY(U,$J,358.3,14771,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,14772,0)
 ;;=198.3^^95^849^11
 ;;^UTILITY(U,$J,358.3,14772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14772,1,4,0)
 ;;=4^198.3
 ;;^UTILITY(U,$J,358.3,14772,1,5,0)
 ;;=5^Brain Metatastasis
 ;;^UTILITY(U,$J,358.3,14772,2)
 ;;=Brain Metatastasis^267334
 ;;^UTILITY(U,$J,358.3,14773,0)
 ;;=197.7^^95^849^28
 ;;^UTILITY(U,$J,358.3,14773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14773,1,4,0)
 ;;=4^197.7
 ;;^UTILITY(U,$J,358.3,14773,1,5,0)
 ;;=5^Ca Liver, Secondary
 ;;^UTILITY(U,$J,358.3,14773,2)
 ;;=CA Liver, Secondary^267328
 ;;^UTILITY(U,$J,358.3,14774,0)
 ;;=197.0^^95^849^52
 ;;^UTILITY(U,$J,358.3,14774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14774,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,14774,1,5,0)
 ;;=5^Mets To Lung
 ;;^UTILITY(U,$J,358.3,14774,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,14775,0)
 ;;=196.2^^95^849^57
 ;;^UTILITY(U,$J,358.3,14775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14775,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,14775,1,5,0)
 ;;=5^Mets to Lymph Nodes, Abdominal
 ;;^UTILITY(U,$J,358.3,14775,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,14776,0)
 ;;=196.3^^95^849^53
 ;;^UTILITY(U,$J,358.3,14776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14776,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,14776,1,5,0)
 ;;=5^Mets To Lymph Nodes, Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,14776,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,14777,0)
 ;;=196.0^^95^849^54
 ;;^UTILITY(U,$J,358.3,14777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14777,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,14777,1,5,0)
 ;;=5^Mets To Lymph Nodes, Cervical
 ;;^UTILITY(U,$J,358.3,14777,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,14778,0)
 ;;=196.1^^95^849^55
 ;;^UTILITY(U,$J,358.3,14778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14778,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,14778,1,5,0)
 ;;=5^Mets To Lymph Nodes, Mediastinal 
 ;;^UTILITY(U,$J,358.3,14778,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,14779,0)
 ;;=196.8^^95^849^56
 ;;^UTILITY(U,$J,358.3,14779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14779,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,14779,1,5,0)
 ;;=5^Mets To Lymph Nodes, Multiple Sites
 ;;^UTILITY(U,$J,358.3,14779,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,14780,0)
 ;;=282.60^^95^849^65
 ;;^UTILITY(U,$J,358.3,14780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14780,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,14780,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,14780,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,14781,0)
 ;;=282.62^^95^849^66
 ;;^UTILITY(U,$J,358.3,14781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14781,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,14781,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,14781,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,14782,0)
 ;;=204.00^^95^849^2
 ;;^UTILITY(U,$J,358.3,14782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14782,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,14782,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,14782,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,14783,0)
 ;;=204.01^^95^849^1
 ;;^UTILITY(U,$J,358.3,14783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14783,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,14783,1,5,0)
 ;;=5^ALL in Remission
 ;;^UTILITY(U,$J,358.3,14783,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,14784,0)
 ;;=204.10^^95^849^15
 ;;^UTILITY(U,$J,358.3,14784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14784,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,14784,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,14784,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,14785,0)
 ;;=204.11^^95^849^14
 ;;^UTILITY(U,$J,358.3,14785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14785,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,14785,1,5,0)
 ;;=5^CLL in Remission
 ;;^UTILITY(U,$J,358.3,14785,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,14786,0)
 ;;=201.90^^95^849^42
 ;;^UTILITY(U,$J,358.3,14786,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14786,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,14786,1,5,0)
 ;;=5^Hodgkin's Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,14786,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,14787,0)
 ;;=200.20^^95^849^46
 ;;^UTILITY(U,$J,358.3,14787,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14787,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,14787,1,5,0)
 ;;=5^Lymphoma, Burkitt's, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,14787,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,14788,0)
 ;;=202.00^^95^849^48
 ;;^UTILITY(U,$J,358.3,14788,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14788,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,14788,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,14788,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,14789,0)
 ;;=200.10^^95^849^47
 ;;^UTILITY(U,$J,358.3,14789,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14789,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,14789,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,14789,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,14790,0)
 ;;=203.00^^95^849^59
 ;;^UTILITY(U,$J,358.3,14790,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14790,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,14790,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,14790,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,14791,0)
 ;;=203.01^^95^849^58
 ;;^UTILITY(U,$J,358.3,14791,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14791,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,14791,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,14791,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,14792,0)
 ;;=238.6^^95^849^60
 ;;^UTILITY(U,$J,358.3,14792,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14792,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,14792,1,5,0)
 ;;=5^Plasmacytoma NOS
 ;;^UTILITY(U,$J,358.3,14792,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,14793,0)
 ;;=205.00^^95^849^4
 ;;^UTILITY(U,$J,358.3,14793,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14793,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,14793,1,5,0)
 ;;=5^AML w/o Remission
 ;;^UTILITY(U,$J,358.3,14793,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,14794,0)
 ;;=205.01^^95^849^3
 ;;^UTILITY(U,$J,358.3,14794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14794,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,14794,1,5,0)
 ;;=5^AML in Remission
 ;;^UTILITY(U,$J,358.3,14794,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,14795,0)
 ;;=205.10^^95^849^17
 ;;^UTILITY(U,$J,358.3,14795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14795,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,14795,1,5,0)
 ;;=5^CML w/o Remission
 ;;^UTILITY(U,$J,358.3,14795,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,14796,0)
 ;;=205.11^^95^849^16
 ;;^UTILITY(U,$J,358.3,14796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14796,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,14796,1,5,0)
 ;;=5^CML in Remission
 ;;^UTILITY(U,$J,358.3,14796,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,14797,0)
 ;;=238.4^^95^849^61
